Interferon gamma in the treatment of patients with moderate COVID-19-Reference-Cited by-同舟云学术

Interferon gamma in the treatment of patients with moderate COVID-19

Published:2021-03-07 Issue:1 Volume:66 Page:47-54
ISSN:2411-2097
Container-title:Problems of Virology
language:
Short-container-title:Voprosy virusologii

Author:

Myasnikov A. L.¹^ORCID,Berns S. A.¹^ORCID,Talyzin P. A.¹^ORCID,Ershov F. I.²^ORCID

Affiliation:

1. Moscow SBIH City Clinical Hospital named after M.E. Zhadkevich of the Moscow City Health Department

2. FSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of the Ministry of Health of Russia

Publisher

Central Research Institute for Epidemiology

Subject

Infectious Diseases,Virology,General Medicine

Reference27 articles.

1. https://clinicaltrials.gov/ct2/results?cond=COVID-19%2C+SARS-CoV-2&term=IFN&cntry=&state=&city=&dist= (accessed December 16, 2020).

2. Dastan F., Nadji S.A., Saffaei A., Marjani M., Moniri A., Jamaa-ti H., et al. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int. Immuno-pharmacol. 2020; 85(106688): 1-5. https://doi.org/10.1016/j.in-timp.2020.106688. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275997/pdf/main.pdf (accessed December 16, 2020).

3. Zhou Q., Chen V, Shannon C.P., Wei X.S., Xiang X., Wang X., et al. In-terferon-a2b Treatment for COVID-19. Front. Immunol. 2020; 11:1-6.

4. Koch T., Dahlke C., Fathi A., Kupke A., Krahling V, Okba N.M.A., et al. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet Infect. Dis. 2020; 20(7): 827-38.

5. Rodriguez-Morales A.J., Cardona-Ospina J.A., Gutierrez-Ocampo E., Villamizar-Pena R., Holguin-Rivera Y, Escalera-Antezana J.P., et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020; 34: 101623.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes;International Journal of Molecular Sciences;2024-06-24

2. Interferon-γ as a Potential Inhibitor of SARS-CoV-2 ORF6 Accessory Protein;International Journal of Molecular Sciences;2024-02-10

3. Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection;Frontiers in Immunology;2024-01-15

4. Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2;Nature Communications;2023-12-12

5. Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2;2023-07-17